Background illustration for clinical trials search

Paid Clinical Trials Santa Fe

Discover 306 paid clinical trials in Santa Fe, New Mexico. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

for
Prostate Cancer, Prostatic Neoplasms
Location: Albuquerque NM, Aurora CO, Phoenix AZ, Las Vegas NV,
Sponsor: Merck Sharp & Dohme LLC

Sex: Male

Age: 18+

Code: NCT06925737

Phase3, Recruiting
Active & Responsive

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

for
Non-small Cell Lung Cancer, NSCLC
Location: Albuquerque NM, Grand Junction CO, Golden CO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06422143

Phase3, Recruiting
Active & Responsive

Enhancing Veteran-Clinical Collaboration in VA PRRCs

for
Schizophrenia, Schizoaffective Disorder, Delusional Disorder,
Location: Albuquerque NM
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT06898879

Recruiting
Active & Responsive

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

for
Obesity, Overweight and/or Obesity, Overweight
Location: Albuquerque NM, San Antonio TX, Escondido CA, Omaha NE,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07595549

Phase3, Recruiting
Active & Responsive

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

for
Obesity, Overweight
Location: Albuquerque NM, Scottsdale AZ, Las Vegas NV, Dallas TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07321886

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

for
Pulmonary Hypertension, Interstitial Lung Disease (ILD),
Location: Albuquerque NM, Kansas City KS, Torrance CA, Houston TX,
Sponsor: Pulmovant, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07333183

Phase2, Recruiting
Active & Responsive

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

for
Heart Failure, Heart Diseases, Cardiovascular Diseases,
Location: Albuquerque NM, Phoenix AZ, Oklahoma City OK,
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT06526195

Recruiting
Active & Responsive

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

for
Percutaneous Coronary Intervention,
Location: Albuquerque NM, Amarillo TX, Englewood CO, Aurora CO,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06909565

Recruiting
Active & Responsive

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

for
Psoriatic Arthritis, Axial Spondyloarthritis
Location: Albuquerque NM, Fort Collins CO, Peoria AZ,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 18+

Code: NCT07290036

Phase1, Recruiting
New

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

for
Influenza, Human
Location: Santa Fe NM, Colorado Springs CO, El Paso TX, Aurora CO,
Sponsor: GlaxoSmithKline

Sex: All

Age: 65+

Code: NCT07805707

Phase3, Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for
HER2-positive Gastric Cancer,
Location: Santa Fe NM, Aurora CO, Phoenix AZ, Dallas TX, Omaha NE,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06764875

Phase3, Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Santa Fe NM, Aurora CO, Tucson AZ, Phoenix AZ,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase3, Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Santa Fe NM, El Paso TX, Denver CO, Aurora CO,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase3, Recruiting

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

for
Metastatic Solid Tumor, Advanced Solid Tumor
Location: Santa Fe NM, Aurora CO, Salt Lake City UT,
Sponsor: Coherus Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06657144

Phase1, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Santa Fe NM, Pueblo CO, Colorado Springs CO,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase3, Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

for
Metastatic Castration-Resistant Prostate Cancer
Location: Santa Fe NM, Mesa AZ, Scottsdale AZ, Gilbert AZ,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT06629779

Phase3, Recruiting

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

for
Relapsed Diffuse Large B-cell Lymphoma,
Location: Santa Fe NM, Omaha NE, Fountain Valley CA,
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)

Sex: All

Age: 18+

Code: NCT04920617

Phase2, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Santa Fe NM, Albuquerque NM, Amarillo TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Santa Fe NM, Lubbock TX, Gilbert AZ, Tucson AZ,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase3, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Santa Fe NM, Lubbock TX, Denver CO, Phoenix AZ,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase3, Recruiting